The Relative Strength (RS) Rating for Heartflow climbed into a higher percentile Wednesday, as it got a lift from 61 to 73.
When To Sell Stocks To Lock In Profits And Minimize Losses
This exclusive rating from Investor's Business Daily measures share price movement with a 1 (worst) to 99 (best) score. The rating shows how a stock's price behavior over the trailing 52 weeks compares to all the other stocks in our database.
Decades of market research shows that the top-performing stocks tend to have an RS Rating of above 80 as they launch their biggest climbs. See if Heartflow can continue to rebound and clear that threshold.
Now is not an ideal time to jump in since it isn't near a proper buy zone, but see if the stock is able to offer and clear a proper buy point.
Heartflow reported 0% earnings growth in its most recent report. Revenue increased 39%.
Heartflow earns the No. 14 rank among its peers in the Computer Software-Medical industry group. OptimizeRx, Veeva Systems Cl A and Doximity are among the top 5 highly rated stocks within the group.
This article was created automatically with Stats Perform's Wordsmith software using data and article templates supplied by Investor's Business Daily. An IBD journalist may have edited the article.
RELATED:
Which Stocks Are Showing Rising Relative Strength?
